(Q37371779)

20 August 2017

1 reference

title

Tobacco addiction and pharmacogenetics of nicotine metabolism (English)

1 reference

Christina N Lessov-Schlaggar

20 August 2017

0 references

series ordinal

2

object named as

Christina N Lessov-Schlaggar

1 reference

20 August 2017

1

Gary E Swan

1 reference

20 August 2017

publication date

19 January 2009

1 reference

20 August 2017

published in

Journal of Neurogenetics

1 reference

20 August 2017

volume

23

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

262-271

1 reference

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Female sex and oral contraceptive use accelerate nicotine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Genetic influences in the variation in renal clearance of nicotine and cotinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Novel genes identified in a high-density genome wide association study for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Genetic and environmental influence on halothane metabolism in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenomics: the inherited basis for interindividual differences in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Mechanisms responsible for sympathetic activation by cigarette smoking in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Metabolism and disposition kinetics of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Genetics of nicotine dependence and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Variability within alpha- and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Allelic variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cardiovascular reactivity in young adult male and female twins of European-American descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Tailoring nicotine replacement therapy: rationale and potential approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Characterization of nicotine and cotinine N-glucuronidations in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Dissecting the genetic architecture of the cardiovascular and renal stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

The scientific case that nicotine is addictive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenetics of nicotine metabolism in twins: methods and procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

A genome-wide screen for nicotine dependence susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

"Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Pharmacogenetics and pharmacogenomics: development, science, and translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Central nervous system serotonin function and cardiovascular responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Nicotine transport in a human choriocarcinoma cell line (JAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

β-2 adrenergic receptor gene variations and blood pressure under stress in normal twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

21 January 2018

When the smoke clears ..

1 reference

https://api.crossref.org/works/10.1080%2F01677060802572903

10.1080/01677060802572903

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference